Exom is the proud winner of this years Corporate Excellence Awards as “Most Innovative Full-Service CRO” which is issued by the Corporate Vision Magazine. “This award is a great honor for Exom and the entire team, who puts a lot of effort in further...
Exom is proud to be awarded as one of the “TOP 30 FASTEST PRIVATE GROWING COMPANIES TO WATCH IN 2021” by the Silicon Review. On this occasion, Dr. Luigi Visani, President and CEO of Exom Group Srl, Speaks to The Silicon Review: ‘Our Mission is to Stay at...
International Phase II/III Clinical Trial on Covid-19 Vaccine Milan (Italy), March 19, 2021 – Exom Group srl, the Full Service, Digital & Green CRO is proud to announce the start of subjects’ recruitment for the Phase II part of COVITAR, a multicenter...
Digital technologies have been used in clinical studies for years. So far, however, they have been used very hesitantly by sponsors, study centers and CROs. Authorities have also been very hesitant to approve their use. The Covid-19 pandemic, however, has changed this...
Digital technologies have been used in clinical studies for years. So far, however, they have been used very hesitantly by sponsors, study centers and CROs. Authorities have also been very hesitant to approve their use. The Covid-19 pandemic, however, has changed this...
Milan, Italy – Exom Group is proud to announce, that we have been awarded the 2020 Healthcare & Pharmaceutical Award for “Most Innovative Clinical Trials Virtualisation CRO 2020”. As an awardee Exom needed to demonstrate expertise within our field, dedication to...
Global Health & Pharma Excellence AwardsAward Winner 2022
Exom is proud to announce that Global Health & Pharma has awarded us the 2022 Global Excellence Award as "Most innovative Full-Service CRO - 2022" for our pioneering, cutting-edge use of technology in clinical trials to support study stakeholders.
